Search research articles
Contact Us
Filters
Showing results (121-130 of 283) with videos related to
Page
of 29
Sort By:
American Journal of Hematology
|
January 14, 2014
Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia
Meagan A Jacoby, Michael G Martin, Geoffrey L Uy, et al.
Haematologica
|
November 4, 2017
Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia
Bruno C Medeiros, Kelly McCaul, Suman Kambhampati, et al.
American Journal of Hematology
|
August 4, 2009
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes
Mike G Martin, Richard A Walgren, Elizabeth Procknow, et al.
Nature Communications
|
May 31, 2020
Evolution and structure of clinically relevant gene fusions in multiple myeloma
Steven M Foltz, Qingsong Gao, Christopher J Yoon, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 9, 2012
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma
Sundar Jagannath, Ravi Vij, A Keith Stewart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 19, 2019
A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance)
Ravi Vij, Jennifer Le-Rademacher, Kristina Laumann, et al.
The Oncologist
|
September 20, 2013
Influence of body mass index on survival in veterans with multiple myeloma
Tracey S Beason, Su-Hsin Chang, Kristen M Sanfilippo, et al.
American Journal of Hematology
|
April 12, 2014
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML
John S Welch, Haixia Niu, Geoffrey L Uy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2004
Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma
Amy L Hoerr, Feng Gao, Josephine Hidalgo, et al.
Leukemia & Lymphoma
|
December 18, 2015
A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia
Lukas D Wartman, Mark A Fiala, Theresa Fletcher, et al.
Page
of 29
Search research articles
Search
Showing results (121-130 of 283) with videos related to
Sort By:
Page
of 29
American Journal of Hematology
|
January 14, 2014
Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia
Meagan A Jacoby, Michael G Martin, Geoffrey L Uy, et al.
Haematologica
|
November 4, 2017
Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia
Bruno C Medeiros, Kelly McCaul, Suman Kambhampati, et al.
American Journal of Hematology
|
August 4, 2009
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes
Mike G Martin, Richard A Walgren, Elizabeth Procknow, et al.
Nature Communications
|
May 31, 2020
Evolution and structure of clinically relevant gene fusions in multiple myeloma
Steven M Foltz, Qingsong Gao, Christopher J Yoon, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 9, 2012
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma
Sundar Jagannath, Ravi Vij, A Keith Stewart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 19, 2019
A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance)
Ravi Vij, Jennifer Le-Rademacher, Kristina Laumann, et al.
The Oncologist
|
September 20, 2013
Influence of body mass index on survival in veterans with multiple myeloma
Tracey S Beason, Su-Hsin Chang, Kristen M Sanfilippo, et al.
American Journal of Hematology
|
April 12, 2014
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML
John S Welch, Haixia Niu, Geoffrey L Uy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2004
Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma
Amy L Hoerr, Feng Gao, Josephine Hidalgo, et al.
Leukemia & Lymphoma
|
December 18, 2015
A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia
Lukas D Wartman, Mark A Fiala, Theresa Fletcher, et al.
Page
of 29